Nav1.1 Sodium Channel Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Nav1.1 Sodium Channel Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NAV1-1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Nav1.1 Sodium Channel</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NAV1-1" target="_blank">Search UniProt</a></td>
</tr>
</table>
Nav1.1 is a voltage-gated sodium channel alpha subunit encoded by SCN1A. In the adult brain, Nav1.1 is enriched in fast-spiking inhibitory interneurons, where it supports high-frequency firing and stabilizes excitation-inhibition balance in cortical and hippocampal circuits.[@claes2001][@ogiwara2007] Reduced Nav1.1 function is strongly linked to epileptic encephalopathies, while network-level Nav1.1 deficits are also relevant to cognitive circuit dysfunction seen in neurodegeneration-associated hyperexcitability.[@ogiwara2007][@verret2012]
Molecular Architecture and Biophysics
Like other Nav alpha subunits, Nav1.1 contains four homologous domains (DI-DIV), each with six transmembrane segments (S1-S6). The S4 segments form voltage sensors, while S5-S6 loops shape the sodium-selective pore.[@catterall2012] Fast inactivation is mediated by the intracellular DIII-DIV linker, which rapidly limits inward sodium current after channel opening.[@catterall2012]
Key functional properties include:
...Nav1.1 Sodium Channel Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Nav1.1 Sodium Channel Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NAV1-1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Nav1.1 Sodium Channel</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NAV1-1" target="_blank">Search UniProt</a></td>
</tr>
</table>
Nav1.1 is a voltage-gated sodium channel alpha subunit encoded by SCN1A. In the adult brain, Nav1.1 is enriched in fast-spiking inhibitory interneurons, where it supports high-frequency firing and stabilizes excitation-inhibition balance in cortical and hippocampal circuits.[@claes2001][@ogiwara2007] Reduced Nav1.1 function is strongly linked to epileptic encephalopathies, while network-level Nav1.1 deficits are also relevant to cognitive circuit dysfunction seen in neurodegeneration-associated hyperexcitability.[@ogiwara2007][@verret2012]
Molecular Architecture and Biophysics
Like other Nav alpha subunits, Nav1.1 contains four homologous domains (DI-DIV), each with six transmembrane segments (S1-S6). The S4 segments form voltage sensors, while S5-S6 loops shape the sodium-selective pore.[@catterall2012] Fast inactivation is mediated by the intracellular DIII-DIV linker, which rapidly limits inward sodium current after channel opening.[@catterall2012]
Key functional properties include:
- Low activation threshold that supports rapid spike initiation.
- Fast activation and inactivation kinetics for repetitive firing.
- Recovery-from-inactivation dynamics that constrain interneuron firing precision under sustained input.[@catterall2012][@catterall2005]
These properties are modulated by beta subunits, phosphorylation state, and membrane microdomain localization at the axon initial segment (AIS).[@catterall2005]
Physiologic Role in Neural Circuits
Nav1.1 is critical for parvalbumin-positive and somatostatin-positive interneuron excitability. Interneuron hypoexcitability from Nav1.1 loss-of-function weakens feedforward and feedback inhibition, increasing pathological synchrony and seizure susceptibility.[@ogiwara2007][@yu2006]
Circuit consequences include:
- Reduced gamma oscillation fidelity.
- Impaired temporal coordination of pyramidal neuron firing.
- Increased vulnerability to runaway excitation under inflammatory or metabolic stress.[@ogiwara2007][@yu2006]
Because inhibitory interneuron dysfunction is also reported in [Alzheimer's disease](/diseases/alzheimers-disease), Nav1.1-centered circuit stabilization remains a translationally interesting strategy beyond primary channelopathy syndromes.[@verret2012]
Disease Relevance
Haploinsufficiency and other loss-of-function variants in SCN1A cause Dravet syndrome and related developmental and epileptic encephalopathies.[@claes2001][@mantegazza2015] The core mechanism is inhibitory interneuron failure rather than primary pyramidal-cell hyperactivity, which explains why non-selective sodium channel blockers can worsen seizures in some patients.[@yu2006][@mantegazza2015]
Alzheimer's Disease and Network Hyperexcitability
Experimental work indicates that interneuron dysfunction can drive network hypersynchrony in Alzheimer's models, with Nav1.1 insufficiency as one mechanistic contributor.[@verret2012] This maps onto clinical observations of subclinical epileptiform activity in some patients with Alzheimer's disease.
Broader Neurodegeneration Context
Although Nav1.1 is not a canonical proteinopathy driver, inhibitory-circuit fragility intersects with [tau](/proteins/tau)- and amyloid-linked network dysfunction. Nav1.1 therefore sits at a mechanistic interface between ion-channel excitability control and degenerative network collapse.[@verret2012][@catterall2012]
Therapeutic Strategies
Precision Channelopathy Approaches
- SCN1A-directed gene replacement and enhancer strategies are under active development.
- Antisense and transcriptional upregulation approaches aim to raise functional Nav1.1 expression in inhibitory [neurons](/entities/neurons).[@mantegazza2015][@han2020]
Symptomatic Network Stabilization
- Dravet-focused regimens use agents that avoid worsening sodium-channel inhibition in susceptible genotypes.
- Adjunct strategies target GABAergic tone and seizure-threshold stabilization while disease-modifying methods are pursued.[@mantegazza2015][@han2020]
Relevance to Neurodegenerative Care
In selected [Alzheimer's disease](/diseases/alzheimers-disease) contexts with epileptiform activity, understanding interneuron sodium-channel biology may help frame biomarker-guided antiseizure choices and trial stratification.[@verret2012]
Evidence and Open Questions
Strong evidence supports Nav1.1 involvement in monogenic epileptic encephalopathy. Evidence in neurodegeneration is biologically plausible but less direct and remains translational.[@verret2012][@mantegazza2015]
Open questions:
- Which patient subsets with neurodegeneration show Nav1.1-dominant inhibitory failure?
- Can EEG phenotyping or interneuron-linked biomarkers identify responders to circuit-targeted therapy?
- What safety profile is acceptable for chronic Nav1.1 augmentation in older adults with multimorbidity?
See Also
- [Nav1.3 Protein](/proteins/nav1-3)
- [Nav1.6 Protein (SCN8A)](/proteins/nav1-6-protein)
- [Neuronal Hyperexcitability Pathway](/mechanisms/neuronal-excitability-pathway)
- [Excitotoxicity Pathway](/mechanisms/excitotoxicity-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
External Links
- [UniProt P35498](https://www.uniprot.org/uniprotkb/P35498/entry)
- [NCBI Gene: SCN1A](https://www.ncbi.nlm.nih.gov/gene/6323)
Brain Atlas Resources
- [Allen Human Brain Atlas - Nav1.1 Expression](https://human.brain-map.org/microarray/search/show?search_term=Nav1.1)
- [Allen Cell Type Atlas - Nav1.1](https://celltypes.brain-map.org/)
- [BrainSpan - Nav1.1 Developmental Expression](https://brainspan.org/)
- [Allen Mouse Brain Atlas - Nav1.1](https://mouse.brain-map.org/)
[@claes2001]: Claes L, Del-Favero J, Ceulemans B, et al. [De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy](https://pubmed.ncbi.nlm.nih.gov/11479712/).
American Journal of Human Genetics. 2001;68(6):1327-1332.
[@ogiwara2007]: Ogiwara I, Miyamoto H, Morita N, et al. [Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epilepsy in mice carrying an Scn1a mutation](https://pubmed.ncbi.nlm.nih.gov/17417630/).
Journal of Neuroscience. 2007;27(22):5903-5914.
[@verret2012]: Verret L, Mann EO, Hang GB, et al. [Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model](https://pubmed.ncbi.nlm.nih.gov/23104071/).
Nature. 2012;487(7405):98-102.
[@catterall2012]: Catterall WA. [Voltage-gated sodium channels at 60: structure, function and pathophysiology](https://pubmed.ncbi.nlm.nih.gov/25287849/).
Journal of Physiology. 2012;590(11):2577-2589.
[@catterall2005]: Catterall WA, Goldin AL, Waxman SG. [International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels](https://pubmed.ncbi.nlm.nih.gov/17157348/).
Pharmacological Reviews. 2005;57(4):397-409.
[@yu2006]: Yu FH, Mantegazza M, Westenbroek RE, et al. [Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy](https://pubmed.ncbi.nlm.nih.gov/17092929/).
Nature Neuroscience. 2006;9(9):1142-1149.
[@mantegazza2015]: Mantegazza M, Gambardella A, Rusconi R, Schiavon E. [From ion channels to epileptic syndromes: clinical and pathophysiological aspects of sodium channel epilepsies](https://pubmed.ncbi.nlm.nih.gov/25420567/).
Epilepsia. 2015;56(9):1202-1218.
[@han2020]: Han Z, Chen C, Christiansen A, et al. [Antisense oligonucleotide therapy for SCN1A encephalopathy in mouse models](https://pubmed.ncbi.nlm.nih.gov/33858922/).
Nature Communications. 2020;11:2204.
References
[Claes L, Del-Favero J, Ceulemans B, et al, De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy (2001)](https://pubmed.ncbi.nlm.nih.gov/11479712/)
[Ogiwara I, Miyamoto H, Morita N, et al, Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epilepsy in mice carrying an Scn1a mutation (2007)](https://pubmed.ncbi.nlm.nih.gov/17417630/)
[Verret L, Mann EO, Hang GB, et al, Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model (2012)](https://pubmed.ncbi.nlm.nih.gov/23104071/)
[Catterall WA, Voltage-gated sodium channels at 60: structure, function and pathophysiology (2012)](https://pubmed.ncbi.nlm.nih.gov/25287849/)
[Catterall WA, Goldin AL, Waxman SG, International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels (2005)](https://pubmed.ncbi.nlm.nih.gov/17157348/)
[Yu FH, Mantegazza M, Westenbroek RE, et al, Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy (2006)](https://pubmed.ncbi.nlm.nih.gov/17092929/)
[Mantegazza M, Gambardella A, Rusconi R, Schiavon E, From ion channels to epileptic syndromes: clinical and pathophysiological aspects of sodium channel epilepsies (2015)](https://pubmed.ncbi.nlm.nih.gov/25420567/)
[Han Z, Chen C, Christiansen A, et al, Antisense oligonucleotide therapy for SCN1A encephalopathy in mouse models (2020)](https://pubmed.ncbi.nlm.nih.gov/33858922/)